Tourette’s Disorder

Clinical picture

• Simple motor tics such as eye blinking, head jerks, and shoulder shrugs usually appear first and progress rostral to caudal.
• Vocal tics range from sniffing, throat clearing, and grunting to words and phrases; coprolalia occurs in only about 10% of patients.
• Premonitory urges, an uncomfortable buildup relieved by performing the tic, are reported by most patients older than about age 10.
• Tics are briefly suppressible, worsen with stress, fatigue, illness, and excitement, and often rebound after periods of suppression.
• Waxing and waning severity over weeks to months, with a shifting tic repertoire, is characteristic and should be expected.
• Impairment more often stems from comorbid ADHD and OCD, social stigma, and musculoskeletal pain than from the tics themselves.

Criteria snapshot

• Requires two or more motor tics and at least one vocal tic, though these need not occur concurrently at any single time.
• Tics must persist for more than one year since first onset, with any duration of tic-free intervals permitted within that year.
• Onset must occur before age 18; later onset suggests functional tic-like behavior or a secondary tic disorder.
• Tics must not be attributable to a substance such as stimulants or cocaine, or to another medical condition such as Huntington disease.
• Persistent motor or vocal tic disorder requires only one modality, and provisional tic disorder lasts less than one year.

Neurobiology

• Dysfunction of cortico-striato-thalamo-cortical circuits, with disinhibition of motor and sensorimotor loops, generates involuntary tics.
• Reduced striatal GABAergic and cholinergic interneuron density is the most consistently replicated postmortem neuropathological finding.
• Dopaminergic hyperinnervation and heightened phasic dopamine release account for the therapeutic response to D2 receptor blockade.
• Heritability is high at roughly 60-80%; rare variants in NRXN1, CELSR3, and histamine decarboxylase have been implicated.
• Reduced supplementary motor area inhibition correlates with premonitory urge intensity on functional and stimulation studies.
• Streptococcal-associated abrupt onset (PANDAS/PANS) remains controversial and does not warrant routine antibody testing.

Psychology

• Tics function as negatively reinforced responses that terminate aversive premonitory urges, progressively strengthening the habit loop.
• Suppression is possible but effortful; sustained inhibition raises internal tension and typically produces later rebound in tic frequency.
• Environmental contingencies such as adult attention, task escape, and family accommodation shape tic frequency and expression.
• Anticipatory anxiety about being observed ticcing drives social withdrawal, school avoidance, and secondary depressive symptoms.
• Habituation to the premonitory urge, rather than willful suppression alone, is the mechanism targeted by behavioral therapy.

Differential & comorbidity

• Differentiate from stereotypies, which are rhythmic, fixed, and urge-free, and from myoclonus, chorea, dystonia, and akathisia.
• Functional tic-like behaviors show abrupt adolescent onset, complex phrases, absent rostrocaudal progression, and social media exposure.
• ADHD co-occurs in about 50-60% and OCD in 30-50%; both usually cause more functional impairment than the tics do.
• Anxiety, learning disorders, rage attacks, self-injurious tics, and sleep disturbance frequently complicate management.
• Consider Wilson disease, Huntington disease, autoimmune encephalitis, and stimulant or neuroleptic effects when onset is atypical or adult.

Pharmacologic treatment

• Alpha-2 agonists are first line for mild to moderate tics: guanfacine 1-4 mg/day or clonidine 0.05-0.4 mg/day in divided doses.
• Aripiprazole 2-20 mg/day has the most favorable benefit-to-harm profile among antipsychotics and carries FDA approval for tics.
• Haloperidol and pimozide are effective but limited by extrapyramidal effects, QTc prolongation, sedation, and tardive risk.
• VMAT2 inhibitors such as tetrabenazine avoid tardive dyskinesia risk; monitor for depression, sedation, and parkinsonism.
• Botulinum toxin injection helps focal disabling tics, and stimulants for comorbid ADHD rarely worsen tics in controlled trials.

Psychotherapy

• CBIT is first line, typically 8 sessions over 10 weeks combining awareness training, competing response, and function-based strategies.
• Habit reversal training yields moderate effect sizes with benefit durable at 6-month follow-up in both children and adults.
• Exposure and response prevention targeting the premonitory urge is an evidence-supported alternative to CBIT in specialty settings.
• ERP for comorbid OCD and parent management training for disruptive behavior are often higher yield than tic-directed treatment.
• Psychoeducation reframing tics as involuntary reduces punitive responses at home and school and lowers patient distress substantially.

Adjunct options

• The Yale Global Tic Severity Scale quantifies severity and tracks treatment response across visits and medication trials.
• School accommodations include permitted tic breaks, separate testing rooms, reduced handwriting demands, and peer education.
• Deep brain stimulation of thalamic or globus pallidus targets is reserved for severe, treatment-refractory adult cases.
• Treat sleep disruption and assess for cervical injury, headache, or pain caused by forceful head and neck tics.
• Advocacy groups and peer support reduce stigma, and most families need explicit reassurance that severity usually declines after adolescence.

Clinical pearls

• Treat the comorbidity first; ADHD and OCD usually impair more than the tics do.
• Abrupt adolescent onset with complex phrases suggests functional tic-like behavior.
• Tics wax and wane, so judge any treatment over months rather than weeks.